JP2009519949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519949A5 JP2009519949A5 JP2008545850A JP2008545850A JP2009519949A5 JP 2009519949 A5 JP2009519949 A5 JP 2009519949A5 JP 2008545850 A JP2008545850 A JP 2008545850A JP 2008545850 A JP2008545850 A JP 2008545850A JP 2009519949 A5 JP2009519949 A5 JP 2009519949A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- des
- peptide
- octapeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75141205P | 2005-12-16 | 2005-12-16 | |
| PCT/US2006/047953 WO2007075439A2 (en) | 2005-12-16 | 2006-12-15 | Compositions and methods for treating obesity and related metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009519949A JP2009519949A (ja) | 2009-05-21 |
| JP2009519949A5 true JP2009519949A5 (https=) | 2010-01-21 |
Family
ID=38218466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008545850A Pending JP2009519949A (ja) | 2005-12-16 | 2006-12-15 | 肥満症および関連する代謝性疾患の治療のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090209460A1 (https=) |
| EP (1) | EP1973953A2 (https=) |
| JP (1) | JP2009519949A (https=) |
| AU (1) | AU2006329836A1 (https=) |
| CA (1) | CA2634016A1 (https=) |
| WO (1) | WO2007075439A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| KR101106510B1 (ko) | 2006-05-30 | 2012-01-20 | 인타르시아 세라퓨틱스 인코포레이티드 | 투피스, 내부채널 삼투압 전달 시스템 유동 조절기 |
| EP2359808B1 (en) | 2006-08-09 | 2013-05-22 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
| US8309522B2 (en) | 2007-02-05 | 2012-11-13 | Amylin Pharmaceuticals, Llc | Neuromedin and FN-38 peptides for treating psychiatric diseases |
| WO2008133908A2 (en) | 2007-04-23 | 2008-11-06 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
| JP2010539002A (ja) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | ウロジラチンの治療剤としての使用 |
| WO2009033690A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Bfgf (119-126) for therapeutic applications |
| CA2726861C (en) * | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| CA2758264A1 (en) * | 2009-04-08 | 2010-10-14 | Takeda Pharmaceutical Company Limited | Neuromedin u derivative |
| PL2427475T3 (pl) * | 2009-05-08 | 2021-07-19 | Techfields Biochem Co., Ltd. | Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami |
| RU2547990C2 (ru) | 2009-09-28 | 2015-04-10 | Интарсия Терапьютикс, Инк. | Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства |
| JP2013209295A (ja) | 2010-10-13 | 2013-10-10 | Takeda Chem Ind Ltd | ペプチド誘導体 |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| RU2730996C2 (ru) | 2015-06-03 | 2020-08-26 | Интарсия Терапьютикс, Инк. | Системы установки и извлечения имплантата |
| KR102574993B1 (ko) | 2016-05-16 | 2023-09-06 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| JP7286542B2 (ja) | 2017-01-03 | 2023-06-05 | インターシア セラピューティクス，インコーポレイティド | Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法 |
| WO2018175924A1 (en) | 2017-03-24 | 2018-09-27 | The Broad Institute, Inc. | Methods and compositions for regulating innate lymphoid cell inflammatory responses |
| WO2024149820A1 (en) | 2023-01-12 | 2024-07-18 | Boehringer Ingelheim International Gmbh | Nmu receptor 2 agonists |
| WO2026013210A1 (en) | 2024-07-11 | 2026-01-15 | Boehringer Ingelheim International Gmbh | Novel nmu receptor 2 agonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7163799B2 (en) * | 2000-04-27 | 2007-01-16 | Merck & Co., Inc. | Neuromedin U receptor NMUR2 and nucleotides encoding it |
| JP2002265497A (ja) * | 2001-03-12 | 2002-09-18 | Tadashi Hashimoto | 生理活性ペプチドニューロメジンｕの高活性誘導体 |
| US8076288B2 (en) * | 2004-02-11 | 2011-12-13 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides having glucose lowering activity |
| EP1829969B1 (en) * | 2004-12-24 | 2012-11-28 | National Cerebral and Cardiovascular Center | Novel polypeptide and the use thereof |
| WO2007022123A2 (en) * | 2005-08-11 | 2007-02-22 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties |
| US8309522B2 (en) * | 2007-02-05 | 2012-11-13 | Amylin Pharmaceuticals, Llc | Neuromedin and FN-38 peptides for treating psychiatric diseases |
-
2006
- 2006-12-15 AU AU2006329836A patent/AU2006329836A1/en not_active Abandoned
- 2006-12-15 EP EP06845564A patent/EP1973953A2/en not_active Withdrawn
- 2006-12-15 CA CA002634016A patent/CA2634016A1/en not_active Abandoned
- 2006-12-15 US US12/097,737 patent/US20090209460A1/en not_active Abandoned
- 2006-12-15 JP JP2008545850A patent/JP2009519949A/ja active Pending
- 2006-12-15 WO PCT/US2006/047953 patent/WO2007075439A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009519949A5 (https=) | ||
| AU2020201322B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| ES2976562T3 (es) | Derivado del glucagón | |
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2006515351A5 (https=) | ||
| BR112013032375B1 (pt) | Conjugado, composição farmacêutica e uso dos mesmos | |
| US12018060B2 (en) | Glucagon derivatives | |
| KR20120128129A (ko) | 심장 병태의 치료 | |
| TW201202265A (en) | Glucagon analogues | |
| RU2012136530A (ru) | Новые соединения, влияющие на пищевое поведение | |
| BR112020003319A2 (pt) | análogo de peptídeo de oxintomodulina acilada | |
| KR20260025094A (ko) | 개선된 특성을 가진 유사체 | |
| WO2024261076A1 (en) | Weight loss | |
| HK40002934B (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| HK40010066B (en) | Glucagon derivative | |
| NZ727090A (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| HK1192261B (zh) | 新型泌酸调节肽衍生物和包含该泌酸调节肽衍生物的用於治疗肥胖的药物组合物 | |
| NZ731342B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| BR112017014205B1 (pt) | Derivados de glucagon e seu uso, e uso de uma composição farmacêutica | |
| NZ717174B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| NZ748012B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| NZ734808B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same |